Desq Long
Sign in

Company

Revolution Medicines, Inc.

RVMD · CIK 0001628171

SEC FORM 4
$5,678.40

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 5,070 shares at $1.12 per share.

Reporting Person ANDERSON ELIZABETH M · Transaction Code M

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001758247-26-000004 · filed 2026-09-24 · View filing →

SEC FORM 4
$174,585.41

Revolution Medicines, Inc. (RVMD)

Sale of 910 shares at $191.8521 per share.

Reporting Person ANDERSON ELIZABETH M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001758247-26-000004 · filed 2026-09-24 · View filing →

SEC FORM 4
$959,805.42

Revolution Medicines, Inc. (RVMD)

Sale of 4,985 shares at $192.5387 per share.

Reporting Person ANDERSON ELIZABETH M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001758247-26-000004 · filed 2026-09-24 · View filing →

SEC FORM 4
$512,227.00

Revolution Medicines, Inc. (RVMD)

Sale of 2,648 shares at $193.4392 per share.

Reporting Person ANDERSON ELIZABETH M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001758247-26-000004 · filed 2026-09-24 · View filing →

SEC FORM 4
$291,883.05

Revolution Medicines, Inc. (RVMD)

Sale of 1,500 shares at $194.5887 per share.

Reporting Person ANDERSON ELIZABETH M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001758247-26-000004 · filed 2026-09-24 · View filing →

SEC FORM 4
$19,515.00

Revolution Medicines, Inc. (RVMD)

Sale of 100 shares at $195.15 per share.

Reporting Person ANDERSON ELIZABETH M · Transaction Code S

Traded Sep 22, 2026 · Disclosed Sep 24, 2026

Source: SEC Form 4 · 0001758247-26-000004 · filed 2026-09-24 · View filing →

SEC FORM 4
$347,402.16

Revolution Medicines, Inc. (RVMD)

Sale of 1,764 shares at $196.94 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 18, 2026 · Disclosed Sep 22, 2026

Source: SEC Form 4 · 0002124509-26-000010 · filed 2026-09-22 · View filing →

SEC FORM 4
$41,536.81

Revolution Medicines, Inc. (RVMD)

Sale of 213 shares at $195.0085 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001246842-26-000008 · filed 2026-09-18 · View filing →

SEC FORM 4
$2,745,401.58

Revolution Medicines, Inc. (RVMD)

Sale of 13,775 shares at $199.3032 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001246842-26-000008 · filed 2026-09-18 · View filing →

SEC FORM 4
$14,820.63

Revolution Medicines, Inc. (RVMD)

Sale of 76 shares at $195.0083 per share.

Reporting Person Horn Margaret A · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001294192-26-000007 · filed 2026-09-18 · View filing →

SEC FORM 4
$974,791.95

Revolution Medicines, Inc. (RVMD)

Sale of 4,891 shares at $199.3032 per share.

Reporting Person Horn Margaret A · Officer Title Chief Operating Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001294192-26-000007 · filed 2026-09-18 · View filing →

SEC FORM 4
$16,575.63

Revolution Medicines, Inc. (RVMD)

Sale of 85 shares at $195.0074 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001462808-26-000010 · filed 2026-09-18 · View filing →

SEC FORM 4
$1,092,978.75

Revolution Medicines, Inc. (RVMD)

Sale of 5,484 shares at $199.3032 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001462808-26-000010 · filed 2026-09-18 · View filing →

SEC FORM 4
$11,895.00

Revolution Medicines, Inc. (RVMD)

Sale of 61 shares at $195 per share.

Reporting Person Anders Jack · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001800668-26-000007 · filed 2026-09-18 · View filing →

SEC FORM 4
$795,618.37

Revolution Medicines, Inc. (RVMD)

Sale of 3,992 shares at $199.3032 per share.

Reporting Person Anders Jack · Officer Title Chief Financial Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001800668-26-000007 · filed 2026-09-18 · View filing →

SEC FORM 4
$974.79

Revolution Medicines, Inc. (RVMD)

Sale of 5 shares at $194.9589 per share.

Reporting Person Sandler Alan B. · Officer Title Chief Development Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001835966-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$66,965.88

Revolution Medicines, Inc. (RVMD)

Sale of 336 shares at $199.3032 per share.

Reporting Person Sandler Alan B. · Officer Title Chief Development Officer · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001835966-26-000006 · filed 2026-09-18 · View filing →

SEC FORM 4
$10,140.45

Revolution Medicines, Inc. (RVMD)

Sale of 52 shares at $195.0087 per share.

Reporting Person Cislini Jeff · Officer Title SVP & General Counsel · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001969082-26-000009 · filed 2026-09-18 · View filing →

SEC FORM 4
$660,490.80

Revolution Medicines, Inc. (RVMD)

Sale of 3,314 shares at $199.3032 per share.

Reporting Person Cislini Jeff · Officer Title SVP & General Counsel · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0001969082-26-000009 · filed 2026-09-18 · View filing →

SEC FORM 4
$5,266.41

Revolution Medicines, Inc. (RVMD)

Sale of 27 shares at $195.0521 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0002124509-26-000008 · filed 2026-09-18 · View filing →

SEC FORM 4
$348,182.69

Revolution Medicines, Inc. (RVMD)

Sale of 1,747 shares at $199.3032 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 18, 2026

Source: SEC Form 4 · 0002124509-26-000008 · filed 2026-09-18 · View filing →

SEC FORM 4
$2,228,625.00

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 52,500 shares at $42.45 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$672,990.53

Revolution Medicines, Inc. (RVMD)

Sale of 3,270 shares at $205.8075 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,630,862.94

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 40,031 shares at $40.74 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code M

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$158,840.16

Revolution Medicines, Inc. (RVMD)

Sale of 800 shares at $198.5502 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$2,367,954.88

Revolution Medicines, Inc. (RVMD)

Sale of 11,833 shares at $200.1145 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$2,683,985.60

Revolution Medicines, Inc. (RVMD)

Sale of 13,368 shares at $200.7769 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$4,326,947.26

Revolution Medicines, Inc. (RVMD)

Sale of 21,447 shares at $201.7507 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$3,831,550.46

Revolution Medicines, Inc. (RVMD)

Sale of 18,869 shares at $203.0606 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$3,659,309.30

Revolution Medicines, Inc. (RVMD)

Sale of 17,949 shares at $203.8726 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$1,023,189.29

Revolution Medicines, Inc. (RVMD)

Sale of 4,995 shares at $204.8427 per share.

Reporting Person Kelsey Stephen Michael · Officer Title See Remarks · Transaction Code S

Traded Sep 11, 2026 · Disclosed Sep 15, 2026

Source: SEC Form 4 · 0001462808-26-000007 · filed 2026-09-15 · View filing →

SEC FORM 4
$314,784.06

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 9,363 shares at $33.62 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code M

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →

SEC FORM 4
$1,223,568.80

Revolution Medicines, Inc. (RVMD)

Sale of 6,019 shares at $203.2844 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →

SEC FORM 4
$1,128,870.42

Revolution Medicines, Inc. (RVMD)

Sale of 5,530 shares at $204.1357 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →

SEC FORM 4
$496,224.15

Revolution Medicines, Inc. (RVMD)

Sale of 2,420 shares at $205.0513 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →

SEC FORM 4
$242,991.31

Revolution Medicines, Inc. (RVMD)

Sale of 1,179 shares at $206.0995 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →

SEC FORM 4
$62,151.99

Revolution Medicines, Inc. (RVMD)

Sale of 300 shares at $207.1733 per share.

Reporting Person Mancini Anthony · Officer Title See Remarks · Transaction Code S

Traded Sep 10, 2026 · Disclosed Sep 14, 2026

Source: SEC Form 4 · 0002124509-26-000004 · filed 2026-09-14 · View filing →

SEC FORM 4
$145,863.06

Revolution Medicines, Inc. (RVMD)

Sale of 706 shares at $206.6049 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$207,124.77

Revolution Medicines, Inc. (RVMD)

Sale of 999 shares at $207.3321 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$748,081.05

Revolution Medicines, Inc. (RVMD)

Sale of 3,587 shares at $208.5534 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$597,874.68

Revolution Medicines, Inc. (RVMD)

Sale of 2,853 shares at $209.56 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$995,678.24

Revolution Medicines, Inc. (RVMD)

Sale of 4,730 shares at $210.5028 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$812,463.23

Revolution Medicines, Inc. (RVMD)

Sale of 3,844 shares at $211.3588 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$78,751.91

Revolution Medicines, Inc. (RVMD)

Sale of 371 shares at $212.2693 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Sep 8, 2026 · Disclosed Sep 10, 2026

Source: SEC Form 4 · 0001193125-26-388156 · filed 2026-09-10 · View filing →

SEC FORM 4
$60,168.00

Revolution Medicines, Inc. (RVMD)

Sale of 300 shares at $200.56 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,329,116.72

Revolution Medicines, Inc. (RVMD)

Sale of 6,597 shares at $201.4729 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$2,615,863.67

Revolution Medicines, Inc. (RVMD)

Sale of 12,919 shares at $202.4819 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$5,324,823.53

Revolution Medicines, Inc. (RVMD)

Sale of 26,160 shares at $203.5483 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$1,485,829.58

Revolution Medicines, Inc. (RVMD)

Sale of 7,271 shares at $204.3501 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$436,639.85

Revolution Medicines, Inc. (RVMD)

Sale of 2,128 shares at $205.1879 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$128,846.25

Revolution Medicines, Inc. (RVMD)

Sale of 625 shares at $206.154 per share.

Reporting Person Kim Lorence H. · Transaction Code S

Traded Aug 31, 2026 · Disclosed Sep 2, 2026

Source: SEC Form 4 · 0001193125-26-380277 · filed 2026-09-02 · View filing →

SEC FORM 4
$378,400.00

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 80,000 shares at $4.73 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$282,738.90

Revolution Medicines, Inc. (RVMD)

Sale of 1,351 shares at $209.2812 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$28,614.63

Revolution Medicines, Inc. (RVMD)

Sale of 136 shares at $210.4017 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$51,808.95

Revolution Medicines, Inc. (RVMD)

Sale of 245 shares at $211.4651 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$26,932.06

Revolution Medicines, Inc. (RVMD)

Sale of 127 shares at $212.0635 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$36,683.52

Revolution Medicines, Inc. (RVMD)

Sale of 177 shares at $207.2515 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$195,234.16

Revolution Medicines, Inc. (RVMD)

Sale of 937 shares at $208.3609 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$294,019.29

Revolution Medicines, Inc. (RVMD)

Sale of 1,405 shares at $209.2664 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$26,510.78

Revolution Medicines, Inc. (RVMD)

Sale of 126 shares at $210.4030 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$48,425.44

Revolution Medicines, Inc. (RVMD)

Sale of 229 shares at $211.4648 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$26,720.08

Revolution Medicines, Inc. (RVMD)

Sale of 126 shares at $212.0641 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$1,062,690.82

Revolution Medicines, Inc. (RVMD)

Sale of 5,128 shares at $207.2330 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$5,191,947.81

Revolution Medicines, Inc. (RVMD)

Sale of 24,917 shares at $208.3697 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$7,520,439.79

Revolution Medicines, Inc. (RVMD)

Sale of 35,938 shares at $209.2615 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$801,670.29

Revolution Medicines, Inc. (RVMD)

Sale of 3,813 shares at $210.2466 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$1,391,205.80

Revolution Medicines, Inc. (RVMD)

Sale of 6,583 shares at $211.3331 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$767,932.99

Revolution Medicines, Inc. (RVMD)

Sale of 3,621 shares at $212.0776 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$39,376.63

Revolution Medicines, Inc. (RVMD)

Sale of 190 shares at $207.2454 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$198,154.92

Revolution Medicines, Inc. (RVMD)

Sale of 951 shares at $208.3648 per share.

Reporting Person GOLDSMITH MARK A · Officer Title See Remarks · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000387 · filed 2026-08-25 · View filing →

SEC FORM 4
$550,860.80

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 29,680 shares at $18.56 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$574,826.00

Revolution Medicines, Inc. (RVMD)

Acquisition (code M) of 26,600 shares at $21.61 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code M

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$704,603.42

Revolution Medicines, Inc. (RVMD)

Sale of 3,400 shares at $207.2363 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$3,609,572.72

Revolution Medicines, Inc. (RVMD)

Sale of 17,323 shares at $208.3688 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$5,402,199.50

Revolution Medicines, Inc. (RVMD)

Sale of 25,817 shares at $209.2497 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$534,072.34

Revolution Medicines, Inc. (RVMD)

Sale of 2,540 shares at $210.2647 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$951,037.65

Revolution Medicines, Inc. (RVMD)

Sale of 4,500 shares at $211.3417 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →

SEC FORM 4
$702,761.21

Revolution Medicines, Inc. (RVMD)

Sale of 3,314 shares at $212.0583 per share.

Reporting Person Cislini Jeff · Officer Title General Counsel · Transaction Code S

Traded Aug 21, 2026 · Disclosed Aug 25, 2026

Source: SEC Form 4 · 0001610717-26-000388 · filed 2026-08-25 · View filing →